Fixed-Duration Venetoclax Regimens Match Continuous BTKi in Frontline CLL

Orlando, FL - ASH 2025- Othman Al Sawaf, MD, speaks during Press Briefing: The Next Wave of Innovation: Breakthrough Blood Cancer Trial Findings at the American Society of Hematology 67th Annual Meeting at the Orange Convention Center here today, Saturday December 6, 2025. The Annual Meeting is the premier hematology event of the year for basic, translational, clinical and population science, in the United States, with hematology experts from around the world attending the meeting. Photo by © ASH/Scott Morgan 2025